Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
MRC Centre for Transplantation, King's College London, London, UK.
Int J Cancer. 2021 Apr 1;148(7):1637-1651. doi: 10.1002/ijc.33339. Epub 2020 Nov 9.
Obesity is a risk factor for several major cancers. Associations of weight change in middle adulthood with cancer risk, however, are less clear. We examined the association of change in weight and body mass index (BMI) category during middle adulthood with 42 cancers, using multivariable Cox proportional hazards models in the European Prospective Investigation into Cancer and Nutrition cohort. Of 241 323 participants (31% men), 20% lost and 32% gained weight (>0.4 to 5.0 kg/year) during 6.9 years (average). During 8.0 years of follow-up after the second weight assessment, 20 960 incident cancers were ascertained. Independent of baseline BMI, weight gain (per one kg/year increment) was positively associated with cancer of the corpus uteri (hazard ratio [HR] = 1.14; 95% confidence interval: 1.05-1.23). Compared to stable weight (±0.4 kg/year), weight gain (>0.4 to 5.0 kg/year) was positively associated with cancers of the gallbladder and bile ducts (HR = 1.41; 1.01-1.96), postmenopausal breast (HR = 1.08; 1.00-1.16) and thyroid (HR = 1.40; 1.04-1.90). Compared to maintaining normal weight, maintaining overweight or obese BMI (World Health Organisation categories) was positively associated with most obesity-related cancers. Compared to maintaining the baseline BMI category, weight gain to a higher BMI category was positively associated with cancers of the postmenopausal breast (HR = 1.19; 1.06-1.33), ovary (HR = 1.40; 1.04-1.91), corpus uteri (HR = 1.42; 1.06-1.91), kidney (HR = 1.80; 1.20-2.68) and pancreas in men (HR = 1.81; 1.11-2.95). Losing weight to a lower BMI category, however, was inversely associated with cancers of the corpus uteri (HR = 0.40; 0.23-0.69) and colon (HR = 0.69; 0.52-0.92). Our findings support avoiding weight gain and encouraging weight loss in middle adulthood.
肥胖是多种主要癌症的一个风险因素。然而,中年体重变化与癌症风险之间的关系并不明确。我们使用欧洲癌症与营养前瞻性调查队列中的多变量 Cox 比例风险模型,研究了中年期间体重和体重指数(BMI)类别变化与 42 种癌症之间的关联。在 241323 名参与者(31%为男性)中,有 20%的人体重减轻,32%的人体重增加(>0.4 至 5.0 公斤/年),持续 6.9 年(平均)。在第二次体重评估后的 8.0 年随访期间,共确定了 20960 例新发癌症。无论基线 BMI 如何,体重增加(每年每增加一公斤)与子宫体癌呈正相关(风险比[HR] = 1.14;95%置信区间:1.05-1.23)。与体重稳定(±0.4 公斤/年)相比,体重增加(>0.4 至 5.0 公斤/年)与胆囊和胆管癌(HR = 1.41;1.01-1.96)、绝经后乳腺癌(HR = 1.08;1.00-1.16)和甲状腺癌(HR = 1.40;1.04-1.90)呈正相关。与保持正常体重相比,保持超重或肥胖 BMI(世界卫生组织类别)与大多数肥胖相关癌症呈正相关。与保持基线 BMI 类别相比,体重增加到更高的 BMI 类别与绝经后乳腺癌(HR = 1.19;1.06-1.33)、卵巢癌(HR = 1.40;1.04-1.91)、子宫体癌(HR = 1.42;1.06-1.91)、肾癌(HR = 1.80;1.20-2.68)和男性胰腺癌(HR = 1.81;1.11-2.95)呈正相关。然而,体重减轻到较低的 BMI 类别与子宫体癌(HR = 0.40;0.23-0.69)和结肠癌(HR = 0.69;0.52-0.92)呈负相关。我们的研究结果支持在中年时期避免体重增加和鼓励体重减轻。